Motor cortex stimulation in patients with Parkinson disease: 12-month follow-up in 4 patients

J Neurosurg. 2008 Jul;109(1):133-9. doi: 10.3171/JNS/2008/109/7/0133.

Abstract

Object: Since the initial 1991 report by Tsubokawa et al., stimulation of the M1 region of cortex has been used to treat chronic pain conditions and a variety of movement disorders.

Methods: A Medline search of the literature published between 1991 and the beginning of 2007 revealed 459 cases in which motor cortex stimulation (MCS) was used. Of these, 72 were related to a movement disorder. More recently, up to 16 patients specifically with Parkinson disease were treated with MCS, and a variety of results were reported. In this report the authors describe 4 patients who were treated with extradural MCS.

Results: Although there were benefits seen within the first 6 months in Unified Parkinson's Disease Rating Scale Part III scores (decreased by 60%), tremor was only modestly managed with MCS in this group, and most benefits seen initially were lost by the end of 12 months.

Conclusions: Although there have been some positive findings using MCS for Parkinson disease, a larger study may be needed to better determine if it should be pursued as an alternative surgical treatment to DBS.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Deep Brain Stimulation / methods*
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Motor Activity / physiology
  • Motor Cortex*
  • Parkinson Disease / pathology
  • Parkinson Disease / physiopathology
  • Parkinson Disease / therapy*
  • Pilot Projects
  • Prospective Studies
  • Recovery of Function / physiology
  • Time Factors
  • Treatment Outcome